Further research is warranted to determine whether there are other mechanisms controlling BST-2 overexpression in breast cancer and whether methylation changes regulate BST-2 expression in other cancers including those in which BST-2 levels are unchanged (Fig 1A) or suppressed (Fig 1B) in tumor tissues compared to their corresponding normal tissues. This evidence concerns the gene BST2 and breast carcinoma.